Skip to content

CING

Cingulate Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.24
+1.75%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 12, 2026
EPS estimate
-$0.43
Revenue estimate
$540.0K

Latest reported

Last report date
Aug 13, 2026
EPS actual
-$0.45
EPS estimate
-$0.63
Revenue actual
Revenue estimate
$166.7K

Track record

Trailing twelve quarters

EPS beats (12Q)
3
EPS misses (12Q)
9
EPS in line (12Q)
0
Avg surprise (4Q)
-38.2%
Revenue beats (12Q)

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$27
PT range
$9.00 – $44
Analysts
2
2 Buy0 Hold0 Sell
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 13, 2026-$0.63-$0.45Beat 28.00%
May 14, 2026-$0.53-$0.95Miss -79.25%
Nov 13, 2025-$0.80-$1.35Miss -68.75%
Aug 19, 2025-$0.82-$1.09Miss -32.93%
May 8, 2025-$1.00-$1.04Miss -4.00%
Mar 27, 2025-$1.48-$0.14Beat 90.54%
Nov 7, 2024-$2.22-$1.83Beat 17.57%
Aug 14, 2023-$0.35-$137Miss -39000.00%
Mar 10, 2023-$86-$98Miss -13.90%
Nov 14, 2022-$0.37-$86Miss -23259.46%
Aug 11, 2022-$0.58-$86Miss -14801.72%
May 12, 2022-$0.23-$106Miss -45830.43%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026